For life sciences startups, intellectual property can be one of a company’s most valuable assets. But knowing what to protect, when to seek protection, and how to build an IP strategy can be challenging, particularly in the early stages.
On August 25, 2026, FundingIP co-hosted a webinar with Women In Bio, focusing on Life Sciences Patent Protection & FundingIP Grants. The session featured Mika Reiner Mayer of Cooley, who shared practical insights on intellectual property in the life sciences, followed by an overview from FundingIP on how our grants can help innovators access professional IP support.
Read the Women In Bio webinar post on LinkedIn →
If you couldn’t make it, here are three key takeaways from the discussion, followed by an important consideration for early-stage companies: how to fund the IP support they need.
1. Start thinking about IP early
Don’t wait until you’re ready to file a patent to start thinking about IP.
One of the clearest messages from the webinar was the importance of developing an IP strategy early on.
For life sciences innovators, timing matters. The presentation highlighted the risks of publicly disclosing an invention before filing a patent application, including the potential impact on novelty in certain jurisdictions.
But early IP planning goes beyond filing dates. Founders should consider what aspects of their innovation may be protectable, who owns the underlying IP, where protection may be needed, and how their IP strategy fits with the company’s development and commercialization plans.
2. Investors look at much more than whether you have a patent
As life sciences companies seek investment, partnerships or other opportunities, their IP can become an important part of due diligence.
Mika’s presentation highlighted several areas investors may examine, including ownership and assignments, freedom to operate, patent prosecution, patent coverage, trade secret protection, prior art and validity risks, and regulatory exclusivity.
The presentation also identified potential IP issues that can create significant problems for companies, including ownership gaps, narrow patent claims, prior disclosure, blocking third-party patents and inventorship disputes.
A strong IP position is about more than having a patent application. Companies should build a strategy that addresses ownership, protection, commercial freedom and potential risks as they grow.
3. Build protection around the whole innovation
A life sciences company’s IP strategy does not necessarily end with a single patent.
The webinar discussed a layered approach to patent protection, which can include the core composition of matter, methods of treatment, formulation and delivery, manufacturing processes, and regulatory or other exclusivities.
The presentation also highlighted the importance of trade secrets for protecting confidential know-how, such as manufacturing processes, cell culture protocols, analytical methods and unpublished regulatory information.
Consider the different elements of your innovation and how patents, trade secrets and other forms of protection can work together.
4. FundingIP makes IP support more accessible
Professional IP support can be a significant cost for innovators. FundingIP provides zero-equity, non-dilutive grants that offer partial or full reimbursement of eligible IP costs, helping innovators access the legal support they need without giving up equity or paying anything back.
We support a broad range of innovators, from independent inventors and startups to Series A-C companies, incubators, accelerators, and technology transfer offices (TTOs).
With access to a global network of 2,000+ IP attorneys, FundingIP helps make professional IP support more accessible, whatever stage an innovator is at.
Interested in protecting your life sciences innovation? Explore FundingIP grants and apply online →
Protecting innovation starts early
The session with Women In Bio and Cooley highlighted an important point for life sciences founders: IP strategy is part of building the company, not something to consider only when a patent application is due.
Starting early can help companies identify what needs protection, address potential ownership and disclosure issues, and build an IP strategy that develops alongside the business.
And when the cost of professional IP support is a barrier, FundingIP grants can help make that support more accessible through zero-equity funding.
Learn more about FundingIP grants →
The information in this article is for general informational purposes only and does not constitute legal advice.